iData Insights

Pergamum AB - Product Pipeline Review – 2015 Now Available at iData Insights

News   •   Dec 01, 2015 10:52 IST

provides an overview of the Pergamum ABs pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pergamum ABs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Pergamum AB including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Pergamum ABs human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Pergamum ABs pipeline products Reasons to buy - Evaluate Pergamum ABs strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Pergamum AB in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Pergamum AB s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Pergamum AB and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pergamum AB - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Pergamum AB and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Pergamum AB Snapshot 4

Pergamum AB Overview 4

Key Information 4

Key Facts 4

Pergamum AB - Research and Development Overview 5

Key Therapeutic Areas 5

Pergamum AB - Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products - Monotherapy 8

Pergamum AB - Pipeline Products Glance 9

Pergamum AB - Clinical Stage Pipeline Products 9

Phase II Products/Combination Treatment Modalities 9

Phase I Products/Combination Treatment Modalities 10

Pergamum AB - Early Stage Pipeline Products 11

Discovery Products/Combination Treatment Modalities 11

Pergamum AB - Drug Profiles 12

DPK-060 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

PXL-01 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

LL-37 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

PXL-181 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Pergamum AB - Pipeline Analysis 16

Pergamum AB - Pipeline Products by Route of Administration 16

Pergamum AB - Pipeline Products by Molecule Type 17

Pergamum AB - Recent Pipeline Updates 18

Pergamum AB - Dormant Projects 20

Pergamum AB - Locations And Subsidiaries 21

Head Office 21

Appendix 22

Methodology 22

Coverage 22

Secondary Research 22

Primary Research 22

Expert Panel Validation 22

Contact Us 22

Disclaimer 23

Read More

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects